Artd1/Parp1 regulates reprogramming by transcriptional regulation of Fgf4 Via Sox2 ADP-Ribosylation

Stem Cells

Volumn 31, Issue 11, 2013, Pages 2364-2373

  Weber, Fabienne A ^a   Bartolomei, Giody ^a   Hottiger, Michael O ^a   Cinelli, Paolo ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Artd1 Parp1; Cell biology; Fgf4; Induced pluripotent stem cells; Pluripotent stem cells; Reprogramming

Indexed keywords

ADP RIBOSYLTRANSFERASE DIPHTHERIA TOXIN LIKE 1; FIBROBLAST GROWTH FACTOR 4; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; CHROMATIN; FEMALE; FIBROBLAST; HISTONE MODIFICATION; IN VITRO STUDY; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

ARTD1/PARP1; CELL BIOLOGY; FGF4; INDUCED PLURIPOTENT STEM CELLS; PLURIPOTENT STEM CELLS; REPROGRAMMING;

ADENOSINE DIPHOSPHATE; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; FIBROBLAST GROWTH FACTOR 4; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; MICE, INBRED C57BL; NUCLEAR REPROGRAMMING; POLY(ADP-RIBOSE) POLYMERASES; SOXB1 TRANSCRIPTION FACTORS;

EID: 84887865391     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1507     Document Type: Article

References (25)

1. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676. (Pubitemid 44233629)
2. Pietronave S, Prat M. Advances and applications of induced pluripo-tent stem cells. Can J Physiol Pharmacol 2012; 90: 317-325.
3. Avilion AA, Nicolis SK, Pevny LH et al. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 2003; 17: 126-140. (Pubitemid 36062514)
4. Chambon P, Weill JD, Mandel P. Nicotinamide mononucleotide activation of new DNA-dependent polyadenylic acid synthesizing nuclear enzyme. Biochem Biophys Res Commun 1963; 11: 39-43.
5. Hassa PO, Haenni SS, Elser M et al. Nuclear ADP-ribosylation reactions in mammalian cells: Where are we today and where are we going? Microbiol Mol Biol Rev 2006; 70: 789-829. (Pubitemid 44484693)
6. Ji Y, Tulin AV. The roles of PARP1 in gene control and cell differentiation. Curr Opin Genet Dev 2010; 20: 512-518.
7. Dantzer F, Santoro R. The expanding role of PARPs in the establishment and maintenance of heterochromatin. FEBS J 2013; 280: 3508-3518.
8. Hemberger M, Nozaki T, Winterhager E et al. Parp1-deficiency induces differentiation of ES cells into trophoblast derivatives. Dev Biol 2003; 257: 371-381. (Pubitemid 36506851)
9. Masutani M, Nozaki T, Watanabe M et al. Involvement of poly(ADP-ribose) polymerase in trophoblastic cell differentiation during tumorigenesis. Mutat Res 2001; 477: 111-117. (Pubitemid 32480194)
10. Gao F, Kwon SW, Zhao Y et al. PARP1 poly(ADP-ribosyl)ates Sox2 to control Sox2 protein levels and FGF4 expression during embryonic stem cell differentiation. J Biol Chem 2009; 284: 22263-22273.
11. Lai Y-S, Chang C-W, Pawlik KM et al. SRY (sex determining region Y)-box2 (Sox2)/poly ADP-ribose polymerase 1 (Parp1) complexes regulate pluripotency. Proc Natl Acad Sci USA 2012; 109: 3772-3777.
12. Doege CA, Inoue K, Yamashita T et al. Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2. Nature 2012; 488: 652-655.
13. Takahashi K, Okita K, Nakagawa M et al. Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc 2007; 2: 3081-3089.
14. Wahlberg E, Karlberg T, Kouznetsova E et al. Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors. Nat Biotechnol 2012; 30: 283-288.
15. Yuan H, Corbi N, Basilico C et al. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev 1995; 9: 2635-2645.
16. Mohammadi M, McMahon G, Sun L et al. Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors. Science 1997; 276: 955-960. (Pubitemid 27209095)
17. Stavridis MP, Lunn JS, Collins BJ et al. A discrete period of FGF-induced Erk1/2 signalling is required for vertebrate neural specification. Development (Cambridge, England) 2007; 134: 2889-2894. (Pubitemid 47386901)
18. Kunath T, Saba-El-Leil MK, Almousailleakh M et al. FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development 2007; 134: 2895-2902. (Pubitemid 47386902)
19. Ying Q-L, Wray J., Nichols J et al. The ground state of embryonic stem cell self-renewal. Nature 2008; 453: 519-523. (Pubitemid 351733324)
20. Feldman B, Poueymirou W, Papaioannou VE et al. Requirement of FGF-4 for postimplantation mouse development. Science (New York, NY) 1995; 267: 246-249.
21. Lanner F, Rossant J. The role of FGF/Erk signaling in pluripotent cells. Development (Cambridge, England) 2010; 137: 3351-3360.
22. Maherali N, Sridharan R, Xie W et al. Directly reprogrammed fibro-blasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem cell 2007; 1: 55-70.
23. Wernig M, Meissner A, Foreman R et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007; 448: 318-324. (Pubitemid 47080337)
24. Meissner A, Wernig M, Jaenisch R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol 2007; 25: 1177-1181. (Pubitemid 47538112)
25. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007; 448: 313-317. (Pubitemid 47080336)